Drug recall · July 14, 2021
Xylocaine-MPF with Epinephrine 1:200 recall
Why: Low out of specification results for epinephrine assay.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37
- Lots / codes
Batch, expiry: Batch 6123435, exp 01/2022; 6124730, 6124731, exp 07/2022
- Quantity
- 234,800 vials
- Company
- Fresenius Kabi USA LLC, Melrose Park, IL
- Distribution
- Distributed Nationwide in the USA
- Initiated
- June 25, 2021 · Voluntary: Firm initiated
- Classified
- July 7, 2021
- Reported
- July 14, 2021
- Ended
- December 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Xylocaine with Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.